
AI in drug discovery — Europe risks watching from the sidelines as US and China accelerate
Since 1950, the cost of developing a new drug has doubled every nine years — Eroom's Law. Today, bringing a molecule to...

Since 1950, the cost of developing a new drug has doubled every nine years — Eroom's Law. Today, bringing a molecule to...

On July 17, 2026, MIT Technology Review covered China's latest AI moonshot: a model exceeding one trillion parameters, t...

On July 17, 2026, MIT Technology Review reported on yet another leap by China in artificial intelligence. This isn't jus...

On July 17, 2026, MIT Technology Review’s newsletter covers two stories: perimenopause misinformation (a symptom of an u...

On July 17, 2026, MIT Technology Review reported China’s latest AI leap: an open-source model matching GPT-4o’s performa...

China’s latest AI leap is here: a model that beats Western benchmarks in language understanding and logical reasoning. T...

On July 17, 2026, MIT Technology Review's The Download highlighted two stories: perimenopause misinformation and China's...

PsiQuantum, a California startup valued at over $3 billion, is assembling a quantum machine that runs on photons, not io...

Two headlines from the same week: four US nuclear reactors hit a major milestone for clean energy production; China inte...

Two news items from the same week: US regulators gave the final go‑ahead for four new nuclear reactors, while China is r...

Sam Altman is back with a proposal: an “AI Dividend” for every US citizen, giving them a stake in the wealth created by...

In mid-2026, OpenAI rolled out its toughest access restrictions ever. According to MIT Technology Review, the company li...